News
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Avemio AG: Acquisition of an 80% stake in L.E.A Investment GmbH and its subsidiary Infinment GmbH
Avemio AG acquires 80% stake in L.E.A Investment GmbH and Infinment GmbH. Transaction expected to close by 31 August 2024. Purchase price in mid-single-digit million Euro range -
-
-
-
-
COMMUNIQUÉ DE PRESSE
GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
GENFIT receives positive opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis, awaiting final European Commission decision. Details in press release -
COMMUNIQUÉ DE PRESSE
GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive
Avis positif du CHMP pour l’Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive. GENFIT annonce l'avis favorable de l'EMA pour le traitement de la CBP avec élafibranor. Décision finale de l'UE en 2024 -
-
COMMUNIQUÉ DE PRESSE
abrdn Income Credit Strategies Fund Announces Update and Tentative Closing Date for Acquisition of Assets From First Trust/abrdn Global Opportunity Income Fund
abrdn Income Credit Strategies Fund announces approval of reorganization with First Trust/abrdn Global Opportunity Income Fund to enhance shareholder benefits and fund viability
